Literature DB >> 12765835

Regulation of heptaspanning-membrane-receptor function by dimerization and clustering.

Rafael Franco1, Meritxell Canals, Daniel Marcellino, Sergi Ferré, Luigi Agnati, Josefa Mallol, Vicent Casadó, Francisco Ciruela, Kjell Fuxe, Carmen Lluis, Enric I Canela.   

Abstract

G-protein-coupled receptors form homomers and heteromers; agonist-induced conformational changes within interacting receptors of the oligomer modify their pharmacology, signalling and/or trafficking. When these receptors are activated, the oligomers rearrange and cluster and a novel mechanism of receptor-operation regulation by oligomer intercommunication is possible. This intercommunication would be assisted by components of the plasma membrane and by scaffolding proteins. Receptor cross-sensitization, cross-desensitization and novel, integrated receptor responses can then develop between oligomeric receptor complexes of the cluster without direct contact between them. This concept gives a new perspective to the understanding of neurotransmission and neuronal plasticity.

Mesh:

Substances:

Year:  2003        PMID: 12765835     DOI: 10.1016/S0968-0004(03)00065-3

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  21 in total

1.  Trafficking of adenosine A2A and dopamine D2 receptors.

Authors:  Maria Torvinen; Carla Torri; Andrea Tombesi; Daniel Marcellino; Stan Watson; Carmen Lluis; Rafael Franco; Kjell Fuxe; Luigi F Agnati
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

2.  Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin.

Authors:  Nicholas J Harmer; Christopher J Robinson; Lucy E Adam; Leopold L Ilag; Carol V Robinson; John T Gallagher; Tom L Blundell
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

Review 3.  Receptor-receptor interactions, receptor mosaics, and basic principles of molecular network organization: possible implications for drug development.

Authors:  Luigi F Agnati; Alexander O Tarakanov; Sergi Ferré; Kjell Fuxe; Diego Guidolin
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 4.  How proteins come together in the plasma membrane and function in macromolecular assemblies: focus on receptor mosaics.

Authors:  Luigi F Agnati; Diego Guidolin; Susanna Genedani; Sergi Ferré; Albertino Bigiani; Amina S Woods; Kjell Fuxe
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 5.  Partners for adenosine A1 receptors.

Authors:  Rafael Franco; Francisco Ciruela; Vicent Casadó; Antonio Cortes; Enric I Canela; Josefa Mallol; Luigi F Agnati; Sergi Ferré; Kjell Fuxe; Carmen Lluis
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module.

Authors:  Sergi Ferré; Luigi F Agnati; Francisco Ciruela; Carme Lluis; Amina S Woods; Kjell Fuxe; Rafael Franco
Journal:  Brain Res Rev       Date:  2007-01-27

Review 7.  G-protein-coupled receptor heteromers: function and ligand pharmacology.

Authors:  R Franco; V Casadó; A Cortés; J Mallol; F Ciruela; S Ferré; C Lluis; E I Canela
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 8.  G-protein-coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitter.

Authors:  Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

9.  Computational study of the heterodimerization between mu and delta receptors.

Authors:  Xin Liu; Ming Kai; Lian Jin; Rui Wang
Journal:  J Comput Aided Mol Des       Date:  2009-02-13       Impact factor: 3.686

10.  Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.

Authors:  Carla Ferrada; Estefanía Moreno; Vicent Casadó; Gerold Bongers; Antoni Cortés; Josefa Mallol; Enric I Canela; Rob Leurs; Sergi Ferré; Carme Lluís; Rafael Franco
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.